FindTrial
Sign In

Analyzing gene sequencing in AML/ALL patients

Whole genome, exome, transcriptome and small-RNA sequencing for AML/ALL samples

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040198
Enrollment
20
Registered
2022-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C925- Acute myelomonocytic leukemia

Interventions

Intervention1: No: No Control Intervention1: No: No

Sponsors

Institute of bioinformatics and applied biotechnology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients diagnoised with acute leukemia

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Identify variants associated with acute leukemia specific to Indian populationTimepoint: 6 months—

Secondary

MeasureTime frame
Profile and study the global transcriptome patterns of DNA repair pathways in acute leukemia samplesTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Sachin suresh jadhav

HCG Cancer Hospital

drsachinjadhav@hotmail.com9741351357

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026